Durham's BioCryst merging with Idera, moving some ops out of state
January 22, 2018 at 14:04 PM EST
Durham’s BioCryst Pharmaceuticals (Nasdaq: BCRX) will merge with Exton, Pennsylvania-based Idera Pharmaceuticals (Nasdaq: IDRA) in an all-stock deal, the companies said Monday.